发明人王建平,陈志强,唐晓军. "一种塞瑞替尼杂质37的合成方法" [P]. 中国发明专利, 专利号 CN 110276281 A, 授权公告日 2020-06-25.
发明人周伟,孙丽萍,冯建国. "Method for the Synthesis of Ceritinib Impurity 37" [P]. 中国发明专利, 专利号 CN 114790973 A, 授权公告日 2021-09-27.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质37 in Pharmaceutical Formulations". J. Chromatogr. A, 2021, 2025, (11), 6528-6547.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质37 as an Impurity". Talanta, 2013, 318, (2), 6868-6886.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 37 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2014, 126, (7), 1329-1346.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质37 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2011, 1127, (12), 2637-2665.